Frazier Life Sciences Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,760,457 shares of BBIO stock, worth $139 Million. This represents 5.15% of its overall portfolio holdings.
Number of Shares
3,760,457
Previous 3,632,604
3.52%
Holding current value
$139 Million
Previous $92 Million
4.05%
% of portfolio
5.15%
Previous 5.42%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
295Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$937 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$932 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$462 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$225 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.5B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...